Treatment of cutaneous abscess: A double-blind clinical study
β Scribed by Jorge L Llera; Richard C Levy
- Publisher
- Elsevier Science
- Year
- 1985
- Tongue
- English
- Weight
- 468 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1097-6760
No coin nor oath required. For personal study only.
β¦ Synopsis
abscess, cutaneous, treatment, antibiotics
Treatment of Cutaneous Abscess: A Double.Blind Clinical Study
Controversy exists about the value of antibiotic therapy following incision and drainage of cutaneous abscess. We undertook a randomized doubleblind study to clarify the controversy. Adult patients with cutaneous abscesses who received outpatient surgical therapy were entered into the study. Following incision and drainage, patients received cephradine or placebo for seven days using a randomized code in a double-blind fashion. At the end of seven days, patients were reevaluated. Twenty-seven patients were treated with cephradine, and 23 with placebo. Ninety-six percent of the patients in each group were improved clinically after seven days. We conclude that cephradine did not alter the outcome of cutaneous abscesses at one week after incision and drainage. The implications are twofold: patients are not exposed to the potential side effects and allergic reactions of antibiotics, and the cost of health care can be reduced by not prescribing antibiotics in these patients.
π SIMILAR VOLUMES
## Abstract __Background.__ Oral leukoplakia and oral erythroplakia may be associated with benign and dysplastic cellular changes, and are at risk of malignant transformation. Additional means of management of these lesions is needed. The results of nonblinded trials using topical bleomycin in oral
There were 22 bulimic women who participated in a double-blind placebo-controlled study of the effects' of imipramine hydrochloride in the treatment of bulimia over a 16 week period. Participants receiving the active drug demonstrated a significantly greater reduction in purging (frequency of self-i
The polyene macrolide candicidin was investigated in the treatment of benign prostatic hyperplasia (BPH). Forty-one unselected patients with BPH and prostatism were admitted to a prospective, double-blind placebo-controlled clinical trial. Patients treated with 270 mg candicidin daily for 6 months h
Twenty-eight patients (12 M, 16 F) with insomnia were treated with nitrazepam 5 mg/d and oxazepam 25 mg/d, each for 11 days, in a double-blind crossover comparison with placebo. Half the patients received nitrazepam in the first drug period, and oxazepam in the second and the other half followed the